Search Results - Koji Miyata

Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects by Hideki Nawa, Hirofumi Hamano, Takahiro Niimura, Koji Miyata, Kenta Yagi, Mitsuhiro Goda, Yoshito Zamami, Keisuke Ishizawa

Connect to this object online.

Asciminib, a novel allosteric inhibitor of BCR‐ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance by Naoki Okamoto, Kenta Yagi, Sayaka Imawaka, Mayu Takaoka, Fuka Aizawa, Takahiro Niimura, Mitsuhiro Goda, Koji Miyata, Kei Kawada, Yuki Izawa‐Ishizawa, Satoshi Sakaguchi, Keisuke Ishizawa

Connect to this object online.

Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage by Toshihiko Yoshioka, Mitsuhiro Goda, Masaya Kanda, Sayuri Itobayashi, Yugo Sugimoto, Yuki Izawa‐Ishizawa, Kenta Yagi, Fuka Aizawa, Koji Miyata, Takahiro Niimura, Hirofumi Hamano, Takumi Sakurada, Yoshito Zamami, Keisuke Ishizawa

Connect to this object online.

Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis by Masaya Kanda, Mitsuhiro Goda, Akiko Maegawa, Toshihiko Yoshioka, Ami Yoshida, Koji Miyata, Fuka Aizawa, Takahiro Niimura, Hirofumi Hamano, Naoto Okada, Takumi Sakurada, Masayuki Chuma, Kenta Yagi, Yuki Izawa‐Ishizawa, Hiroaki Yanagawa, Yoshito Zamami, Keisuke Ishizawa

Connect to this object online.

Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination by Takahiro Niimura, Takahiro Niimura, Mitsuhiro Goda, Mitsuhiro Goda, Koji Miyata, Jun Matsumoto, Toshihiko Yoshioka, Toshihiko Yoshioka, Hirofumi Hamano, Hirofumi Hamano, Fuka Aizawa, Fuka Aizawa, Kenta Yagi, Kenta Yagi, Yuki Izawa-Ishizawa, Yuki Izawa-Ishizawa, Yoshito Zamami, Yoshito Zamami, Keisuke Ishizawa, Keisuke Ishizawa, Keisuke Ishizawa

Connect to this object online.